🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is an open-label drug-drug interaction (DDI) study of ZYN002 tra...
Status
Completed
Location
CMAX Clinical Research
Start Date
2025-06-06
Trial ID
NCT06930872
This study investigates the pharmacokinetics of yohimbine in women and men ...
Status
Completed
Location
University Medicine Greifswald, Institute of Pharmacology
Start Date
2025-04-28
Trial ID
NCT06939608
Treatments Being Tested
This study aimed to investigate the influence of uncontrolled type 1 and ty...
Status
Completed
Location
Universidade Estadual Paulista Julio de Mesquita Filho
Start Date
2008-06
Trial ID
NCT02246712
Treatments Being Tested
The purpose of this study is to evaluate the effects of multiple doses of a...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2010-01
Trial ID
NCT01017939
Treatments Being Tested
Phenotyping is an approach largely used for the evaluation of the activity ...
Status
Completed
Location
University Hospitals
Start Date
2012-11
Trial ID
NCT01731067
Treatments Being Tested
PEGASUS aims to test acceptability and feasibility of studying phenoconvers...
Status
Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2025-07-22
Trial ID
NCT06383338
Treatments Being Tested
Human safety studies will be carried out to test whether red clover botanic...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2019-04-01
Trial ID
NCT03948243
Treatments Being Tested
The goal of this observational study aims to reveal the pharmacokinetics of...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2023-03-28
Trial ID
NCT05893849
Treatments Being Tested
The main purpose of this study is to determine the potential inhibitory/ind...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2017-03-14
Trial ID
NCT03058419
Primary Objective: To assess the effect of repeated once-daily oral doses ...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2016-10
Trial ID
NCT02940379
Treatments Being Tested